1. Casas J, Friedman DF, Jackson T, Vege S, Westhoff CM, Chou ST. Changing practice: red blood cell typing by molecular methods for patients with sickle cell disease. Transfusion. 2015; 55:1388–1393. PMID:
25573464.
2. Keller MK. The role of red cell genotyping in transfusion medicine. Immunohaematology. 2015; 31:49–52.
3. Fung MK, Hillyer CD, Grossman BJ, Westhoff CM. Technical Manual. 18th ed. Bethesda, MD: AABB Press;2014.
4. Hong YJ, Chung Y, Hwang SM, Park JS, Kwon JR, Choi YS, et al. Genotyping of 22 blood group antigen polymorphisms and establishing a national recipient registry in the Korean population. Ann Hematol. 2016; 95:985–991. PMID:
27021300.
5. Park MH, Son J, Go JW, Kim JY, Ahn DH, Kim DA. A case of hemolytic disease of the newborn due to anti-Dib Antibody. J Korean Soc Neonatol. 1999; 6:268–267.
6. Choi JW, Kim MJ, Kim MH, Park JR, Kim HO. A case of mild hemolytic disease of the fetus and newborn - The first case of anti-Dib identified on prescreening test during pregnancy. Korean J Blood Transfus. 2010; 21:165–170.
7. Kim HC, Kang MJ, Chae JH, Shim WS, Nahm CH, Hah KS. A case of hemolytic disease of the newborn due to anti-Dib antibody. Korean J Blood Transfus. 1994; 5:151–158.
8. Oh EJ, Jekarl DW, Jang HS, Park HI, Park YJ, Choi HA, et al. Severe hemolytic disease of the newborn due to anti-Dib treated with phototherapy and intravenous immunoglobulin. Ann Clin Lab Sci. 2008; 38:80–82. PMID:
18316786.
9. Lee MY, Park TS, Oh SH, Kim SY, Kim HO. Two clinical cases of anti-Dib with Di(a+b−) phenotypes: practical need for rare blood donor registry program in Korea. Lab Med Online. 2017; 7:79–82.
10. Flegel WA, Gottschall JL, Denomme GA. Integration of red cell genotyping into the blood supply chain: a population-based study. Lancet Haematol. 2015; 2:e282–e288. PMID:
26207259.